ASP Isotopes Inc. is a development stage advanced materials company. The Company is engaged in the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (ASP technology). Its initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Its Nuclear Fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment is focused on research and development of technologies and methods used to separate high-value, low-volume isotopes (such as C-14, Mo-100, and Si-28) for highly specialized target end markets other than advanced nuclear fuels, including pharmaceuticals and agrochemicals, nuclear medical imaging, and others.
企業コードASPI
会社名ASP Isotopes Inc
上場日Nov 10, 2022
最高経営責任者「CEO」Mr. Paul Elliot Mann
従業員数136
証券種類Ordinary Share
決算期末Nov 10
本社所在地601 Pennsylvania Avenue Nw
都市WASHINGTON
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号20004
電話番号12027562245
ウェブサイトhttps://aspisotopes.com/
企業コードASPI
上場日Nov 10, 2022
最高経営責任者「CEO」Mr. Paul Elliot Mann
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし